Evidence map›Paper›PMID 27070822›Full record

ArticleThe American journal of pathology2016

Enhanced Muscular Dystrophy from Loss of Dysferlin Is Accompanied by Impaired Annexin A6 Translocation after Sarcolemmal Disruption.

Alexis R Demonbreun, Madison V Allen, James L Warner, David Y Barefield, Swathi Krishnan, Kaitlin E Swanson, Judy U Earley, Elizabeth M McNally

Open access · greenAbstract read
In one paragraph

Article in The American journal of pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Annexins and Membrane Repair Dysfunctions in Muscular Dystrophies.International journal of molecular sciences · 2021
    Review
  10. Annexin Animal Models-From Fundamental Principles to Translational Research.International journal of molecular sciences · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Cholesterol and the Safety Factor for Neuromuscular Transmission.International journal of molecular sciences · 2019
    Review
  17. Article
  18. Regulation of fibrosis in muscular dystrophy.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alexis R DemonbreunCenter for Genetic Medicine, Northwestern University, Chicago, Illinois. Electronic address: alexis.demonbreun@northwestern.edu.
Madison V AllenCenter for Genetic Medicine, Northwestern University, Chicago, Illinois.
James L WarnerCenter for Genetic Medicine, Northwestern University, Chicago, Illinois.
David Y BarefieldCenter for Genetic Medicine, Northwestern University, Chicago, Illinois.
Swathi KrishnanDepartment of Medicine, The University of Chicago, Chicago, Illinois.
Kaitlin E SwansonDepartment of Pathology, The University of Chicago, Chicago, Illinois.
Judy U EarleyCenter for Genetic Medicine, Northwestern University, Chicago, Illinois.
Elizabeth M McNallyCenter for Genetic Medicine, Northwestern University, Chicago, Illinois.
Northwestern University · USUniversity of Chicago · US

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
Training and education CoreU54AR052646 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI MCNALLY, ELIZABETH M, SWEENEY, H LEE · 2005 to 2020
$24.1M
Myoferlin in Muscle Membrane Fusion and RepairR01NS047726 · NINDS · UNIVERSITY OF CHICAGO · PI ALEXIS R. DEMONBREUN, Elizabeth M McNally · 2003 to 2026
$7.2M
Understanding and Improving Therapies for the Muscular Dystrophies through Noninvasive BiomarkersP50AR052646 · NIAMS · UNIVERSITY OF FLORIDA · PI WALTER, GLENN · 2021 to 2024
$6.2M
Regulation of TGF - (beta) pathways in muscular dystrophy fibrosisP01NS072027 · NINDS · UNIVERSITY OF CHICAGO · PI HEYDEMANN, AHLKE · 2011 to 2015
$6.2M
Olympus FV1000MPE Multiphoton MicroscopeS10OD010398 · OD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CHEW, TENG-LEONG · 2012 to 2012
$551k
Myosin binding protein H-like and its role in cardiomyopathyF32HL131304 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BAREFIELD, DAVID Y · 2016 to 2018
$155k
NCATS NIH HHS UL1 TR001422NHLBI NIH HHS F32 HL131304NIAMS NIH HHS P50 AR052646NIAMS NIH HHS U54 AR052646NIH HHS S10 OD010398NINDS NIH HHS P01 NS072027NINDS NIH HHS R01 NS047726
6 · The paper itself

Abstract

Dysferlin is a membrane-associated protein implicated in membrane resealing; loss of dysferlin leads to muscular dystrophy. We examined the same loss-of-function Dysf mutation in two different mouse strains, 129T2/SvEmsJ (Dysf(129)) and C57BL/6J (Dysf(B6)). Although there are many genetic differences between these two strains, we focused on polymorphisms in Anxa6 because these variants were previously associated with modifying a pathologically distinct form of muscular dystrophy and increased the production of a truncated annexin A6 protein. Dysferlin deficiency in the C57BL/6J background was associated with increased Evan's Blue dye uptake into muscle and increased serum creatine kinase compared to the 129T2/SvEmsJ background. In the C57BL/6J background, dysferlin loss was associated with enhanced pathologic severity, characterized by decreased mean fiber cross-sectional area, increased internalized nuclei, and increased fibrosis, compared to that in Dysf(129) mice. Macrophage infiltrate was also increased in Dysf(B6) muscle. High-resolution imaging of live myofibers demonstrated that fibers from Dysf(B6) mice displayed reduced translocation of full-length annexin A6 to the site of laser-induced sarcolemmal disruption compared to Dysf(129) myofibers, and impaired translocation of annexin A6 associated with impaired resealing of the sarcolemma. These results provide one mechanism by which the C57BL/6J background intensifies dysferlinopathy, giving rise to a more severe form of muscular dystrophy in the Dysf(B6) mouse model through increased membrane leak and inflammation.

Indexed as

AnimalsAnnexin A6DysferlinImmunoblottingMembrane ProteinsMiceMice, 129 StrainMice, Inbred C57BLMice, Mutant StrainsMuscular Dystrophy, AnimalPolymerase Chain ReactionPolymorphism, Single NucleotideProtein TransportSarcolemmaAnnexin A6DysferlinDysf protein, mouseMembrane Proteins

Identifiers

PMID27070822
PMCPMC4901136
OpenAlexW2312857829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.